Nasdaq Biotechnology Ishares ETF (NQ: IBB )
138.95 USD +0.70 (+0.51%) Official Closing Price Updated: 7:59 PM EST, Nov 25, 2020 Add to My Watchlist
Press releases about Nasdaq Biotechnology Ishares ETF
Compugen Added to the NASDAQ Biotechnology Index
December 20, 2019
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has been selected for addition to the NASDAQ...
From PR Newswire
BioDelivery Sciences Added to NASDAQ Biotechnology Index
December 19, 2019
Castle Biosciences Added to NASDAQ Biotechnology Index
December 18, 2019
Affimed Announces Addition to NASDAQ Biotechnology Index
December 17, 2019
Mirati Therapeutics Added To NASDAQ Biotechnology Index
December 20, 2018
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq: ^NBI). The...
From PR Newswire
Strongbridge Biopharma plc Added to the NASDAQ Biotech Index
December 12, 2017
Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet...
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index
December 11, 2017
Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) announced today that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq:^NBI), which will become effective prior to...
BlackRock Announces Share Split for iShares Nasdaq Biotechnology ETF
November 07, 2017
BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB).
MediciNova Added to NASDAQ Biotechnology Index
December 13, 2016
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the Company...
All Penny Stocks.com News: Organovo Soars on Strong Customer Response for Its Second Tissue Service
November 01, 2016
All Penny Stocks.com News: Cellceutix Phase 2 Trial Preliminary Data Shows Potential of Brilacidin
October 11, 2016
All Penny Stocks.com News: Lipocine's Shares Surge as Company's Oral Testosterone Replacement Therapy Successful in Mid-Stage Study
September 26, 2016
All Penny Stocks.com News: AXIM Biotechnologies Signs Distribution Agreement with Rafa Pharmaceuticals
September 19, 2016
Biotech Industry on the Upswing after Rocky Start to 2016
August 17, 2016
AllPennyStocks.com News: Organovo Holdings Rallies as Company Signs First Customer Orders for Kidney Tissue Early Access Program
July 20, 2016
Vista Partners Initiates Coverage on Mount TAM Biotechnologies, Inc. (Ticker: MNTM); $3.25 Price Target
June 30, 2016
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, Fintech, Healthcare, IoT, SaaS, Sports, WearableTech & More
All Penny Stocks.com News: Aytu Bioscience Outlines Commercial Expansion Plans to Support Launch of New Drug
May 18, 2016
All Penny Stocks.com News: ProtoKinetix's AAGP(TM) Improves Results in Stem Cells Transplanted in Retina Significantly
May 02, 2016
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, CyberSecurity, Fintech, Healthcare, IoT, Basketball, Retail, SaaS, Thrift Stores, WearableTech &...
Four Biotech Stocks To Consider As The Sector Breaks Out
April 07, 2016
Stocks That Demand Your Attention and Consideration Right Now
February 29, 2016
Past Winner Spotlight: ENDV, PPCH, EYES, LPCN, GALE
February 28, 2016
3 Stocks That Should be in Your Portfolio Today
February 26, 2016